- Active pharmaceutical ingredients or API company, Divi’s Laboratories has selected Juniper ( NYSE: JNPR ) to deliver highly available, ultra-reliable networking solutions across its manufacturing operations.
- India-based Divi’s Labs strategically partners with many of the leading pharma companies, manufacturing and custom synthesizing APIs for products used in over 95 countries including antidepressants, blood pressure medicine, antihistamines and more.
- The network upgrades from Juniper have provided Divi’s Labs with a highly secure, highly available and ultra-reliable network to continue producing world-class APIs.
- Their data center also fully runs on Juniper gear, driving critical manufacturing processes.
For further details see:
Divi's Labs selects Juniper for networking solutions across manufacturing facilities